Division of Surgical Oncology

The MasSpec Pen is a handheld device that enables surgeons to discriminate between tumor and healthy tissues as they operate.

Division Highlights

  • The GI Surgery program achieved a “Best Performing” rank in U.S. News & World Report, and all our eligible procedure and diagnosis areas received the highest applicable rating of “High Performing”
  • Surpassed 400 trans-oral thyroid procedures and 100 thyroid ablation procedures, one of the largest such programs in the United States
  • First program in Texas to offer thyroid artery embolization for treatment of thyroid tumors
  • VA program is first in the country to be recognized as National Pancreas Foundation Centers of Excellence
  • Dr. Atif Iqbal launched a first-of-its-kind “IIT” chemoimmunotherapy trial (NICER trial) for primary colon cancer
  • Launched new endocrine fellowship, offering training in advanced trans-oral thyroid surgery
Dr. Ernest Ramsay Camp

Chief's Message

View a message from the Division of Surgical Oncology Chief, E. Ramsay Camp, M.D.

View Message
Surgery Residents Dr. Carter, Dr. Scully and Dr. Mason.

Education

Our residents are exposed to a broad range of clinical opportunities at a total of six major hospital affiliates. 

Explore Training Programs
Scott Holmes, CMI
SNAI1 drives dysfunction of sphingolipid metabolism by activating S1P pathways to amplify TIC self-renewal capacity and RT resistance

Research

Explore clinical and basic science research from the Division of Surgical Oncology.

Our Research
endocrine surgery clinic

Healthcare

Explore Surgical Oncology healthcare specialty areas from the division.

Healthcare Offerings